Randomized Phase II Trial of Sulindac for Lung Cancer Chemoprevention

INTRODUCTION: Sulindac represents a promising candidate agent for lung cancer chemoprevention, but clinical trial data have not been previously reported. We conducted a randomized, phase II chemoprevention trial involving current or former cigarette smokers (≥ 30 pack-years) utilizing the multi-cent...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Limburg, Paul J., Mandrekar, Sumithra J., Aubry, Marie Christine, Ziegler, Katie L. Allen, Zhang, Jun, Yi, Joanne E., Henry, Michael, Tazelaar, Henry D., Lam, Stephen, McWilliams, Annette, Midthun, David E., Edell, Eric S., Rickman, Otis B., Mazzone, Peter, Tockman, Melvyn, Beamis, John F., Lamb, Carla, Simoff, Michael, Loprinzi, Charles, Szabo, Eva, Jett, James
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566344/
https://ncbi.nlm.nih.gov/pubmed/23261228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2012.11.011
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker